Appaji Mandhare Ph.D.
Dr. Mandhare is a drug development professional with over 28 years of expert hands-on knowledge in computation chemistry, advanced molecular modeling, pharmacophore mapping and molecular docking methodologies. He has developed predicative hypothesis models and virtual screening assays to create novel backbones with planned physicochemical properties and toxicities. He has applied various advanced in-silico techniques and knowledge based artificial intelligence concepts in the lead identification and lead optimization processes.
Dr. Mandhare received his Ph.D. from National Chemical Laboratory (NCL). Following this, he was associated with Core Healthcare Ltd, where he was instrumental in setting up a CADD program. As a Senior scientist at Torrent Research Center (TRC), he participated in the development of leads in several therapeutic areas including hypertension, metabolic disorders, cardiovascular and respiratory diseases. He is also the author of a number of key national and international scientific publications and product patents.
At VRise his responsibilities include overseeing Medicinal Chemistry and CADD program.
Prashant Bhavar - Founder & Designated Partner
With an extensive background in pharmaceutical research spanning over 24 years, Prashant has excelled in drug discovery and development research. As a distinguished inventor of multiple novel therapeutics, Prashant has played a pivotal role in establishing numerous drug development collaborations and leading global partnering activities. His expertise extends to crafting and implementing global scientific and corporate strategies for IP-driven R&D enterprises.
Uday Kumar S. - Founder & Designated Partner
Uday Kumar brings a wealth of industry leadership in strategic biotech operations and a comprehensive understanding of groundbreaking therapeutic technologies. He has consistently demonstrated success in guiding products through the entire spectrum, from early discovery pipelines to late-clinical stages. His expertise spans various therapeutic areas, including oncology, inflammation, metabolic disorders, pain, and inhalation technology.